Trade EIKN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Eikon Therapeutics, Inc. (EIKN) is trading at US$6.72, down 7.44% today as of Oct 13, 16:00 EDT. The company has a market capitalisation of US$616.94M. Over the past 52 weeks, EIKN has traded between US$6.71 and US$18.00. On Syfe you can trade EIKN with $0 commission and add it to your watchlist.
| Previous close | US$7.26 |
|---|---|
| Market cap | US$616.94M |
| 52-week range | US$6.71 – US$18.00 |
| Volume | 406.6K |
| Exchange | US |
Eikon Therapeutics, Inc.
Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.
Year: 2026
Eikon Therapeutics Selects Dose in Phase 2/3 Trial of Investigational Melanoma Treatment
Aug 11, 12:41 PM · MT Newswires
Eikon Therapeutics Doses First Patient in Phase 2/3 Trial for EIK1001 in Non-Small Cell Lung Cancer
Jul 27, 12:16 PM · MT Newswires
Eikon Therapeutics to Join Russell 3000 Index After Annual Reconstitution
Jun 25, 8:48 PM · MT Newswires
Wedbush Cuts Price Target on Eikon Therapeutics to $5 From $7, Keeps Underperform Rating
May 12, 12:11 PM · MT Newswires
Eikon Therapeutics, Inc. (EIKN) stock is trading at US$6.72, -7.44% from the previous close of US$7.26.
The market cap for Eikon Therapeutics, Inc. (EIKN) stock is approximately US$616.94M.
The 52-week high for Eikon Therapeutics, Inc. (EIKN) stock is US$18.00.
The 52-week low for Eikon Therapeutics, Inc. (EIKN) stock is US$6.71.
Eikon Therapeutics, Inc. (EIKN) does not currently pay a dividend.
Stay on top of EIKN
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
